Evolution of the Average Target: Stride, Inc.

Evolution of the Target Price: Stride, Inc.

Changes in Analyst Recommendations: Stride, Inc.

43f4da5e6a2f7.DOgO0JvooHHUw254cqVywljULG5MlIIkAeSa2ZW38nc.Iapil-Ks8zWtnC0MCpJKsxO9e10l8vBla5XUi9vcuxxckH6l3KbqAp6VAQ~2b9a4e3222f90e6a0d5b8149906b2a2e
29/10/25 Morgan Stanley Lowers Price Target on Stride to $130 From $159, Keeps Equalweight Rating MT
29/10/25 BMO Capital Downgrades Stride to Market Perform From Outperform, Adjusts PT to $108 From $164 MT
06/10/25 Analyst recommendations: Micron, Nike, Stellantis, Microsoft, Newmont Corp… Zonebourse
29/08/25 Barrington Raises Price Target on Stride to $185 From $170, Keeps Outperform Rating MT
06/08/25 Morgan Stanley Raises Price Target on Stride to $159 From $148, Keeps Equalweight Rating MT
05/08/25 Stride Q4 revenue, adjusted EPS beat estimates RE
30/04/25 Barrington Research Adjusts Stride's Price Target to $170 From $150, Keeps Outperform Rating MT
30/04/25 Morgan Stanley Raises Price Target on Stride to $148 From $141, Keeps Equalweight Rating MT
21/04/25 Stride Positioned for 'Beat, Raise' in Fiscal Q3 Amid Strong Enrollments, Morgan Stanley Says MT
21/04/25 Morgan Stanley Raises Price Target on Stride to $141 From $117, Keeps Equalweight Rating MT
29/01/25 Barrington Adjusts Price Target on Stride to $140 From $130, Maintains Outperform Rating MT
23/10/24 Morgan Stanley Raises Price Target on Stride to $94 From $74, Keeps Equalweight Rating MT
20/08/24 Stride Shares Fall After Citigroup Downgrade MT
20/08/24 Citigroup Downgrades Stride to Neutral From Buy, Adjusts Price Target to $90 From $77 MT
08/08/24 Barrington Research Adjusts Stride's PT to $90 From $85, Keeps Outperform Rating MT
08/08/24 Canaccord Genuity Initiates Coverage on Stride With Buy Rating, $94 Price Target MT
31/07/24 Barrington Research Adjusts Stride's Price Target to $85 From $75, Keeps Outperform Rating MT
24/04/24 Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating MT
25/01/24 BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating MT
25/01/24 Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating MT
24/01/24 Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating MT
16/11/23 BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating MT
16/11/23 Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating MT
26/10/23 BMO Capital Raises Price Target on Stride to $57 From $50, Maintains Outperform Rating MT
25/10/23 Barrington Raises Price Target on Stride to $60 From $50, After Q1/24 Earnings Top Estimates, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+36.16%
+51.75%
+70.98%
+12.62%
+32.54%
+44.98%
+18.98%
- - +36.82%
- +28.4%
+15.58%
Average +34.88%
Weighted average by Cap. +38.49%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
83.36USD
Average target price
113.50USD
Spread / Average Target
+36.16%
High Price Target
125.00USD
Spread / Highest target
+49.95%
Low Price Target
102.00USD
Spread / Lowest Target
+22.36%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BMO Capital
Morgan Stanley
Barrington Research
Citigroup
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
83.36USD
Average target price
113.50USD
Spread / Average Target
+36.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LRN Stock
  4. Consensus Stride, Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!